ACTB-1003 – 5 mg

Brand:
Cayman
CAS:
939805-30-8
Storage:
-20
UN-No:
Non-Hazardous - /

ACTB-1003 is a multi-kinase inhibitor (IC50s = 6, 2, 4, 5, and 32 nM for FGFR1, VEGFR2, Tie-2, RSK, and p70S6K, respectively).{49609} It inhibits growth of OPM2 human multiple myeloma and murine Ba/F3-TEL-FGFR1 leukemia cells in vitro. ACTB-1003 inhibits tumor angiogenesis in an H460 mouse xenograft model. It also reduces tumor growth in an HCT116 mouse xenograft model when administered in combination with 5-fluorouracil (5-FU; Item No. 14416) or paclitaxel (Item No. 10461).  

 

Available on backorder

SKU: 30069 - 5 mg Category:

Description

A multi-kinase inhibitor (IC50s = 6, 2, 4, 5, and 32 nM for FGFR1, VEGFR2, Tie-2, RSK, and p70S6K, respectively); inhibits growth of OPM2 human multiple myeloma and murine Ba/F3-TEL-FGFR1 leukemia cells in vitro; inhibits tumor angiogenesis in an H460 mouse xenograft model; reduces tumor growth in an HCT116 mouse xenograft model when administered in combination with 5-FU or paclitaxel


Formal name: N-[4-[4-amino-6-(methoxymethyl)-7-(4-morpholinylmethyl)pyrrolo[2,1-f][1,2,4]triazin-5-yl]-2-fluorophenyl]-N′-[2-fluoro-5-(trifluoromethyl)phenyl]-urea

Synonyms: 

Molecular weight: 591.5

CAS: 939805-30-8

Purity: ≥98%

Formulation: A crystalline solid